Indications and uses
Use to regrow hair on the scalp (vertex only, see picture on side of carton)
Fete Health Hair Regrowth Treatment for Women
- Manufacturer
- Honest Pharma LLC | Pure Source, LLC
- Effective date
- 2026-02-11
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 01:43:58
Label at a glance#
ProductFete Health Hair Regrowth Treatment for Women
Active ingredientMINOXIDIL
Label structure8 sections
Dosage and administration
apply one mL with dropper 2 times a day directly onto the scalp in the hair loss area using more or more often will not improve results continued use is necessary to increase and keep your hair regrowth, or hair loss will begin again
Contacts and useful links#
Label contents#
Full prescribing information#
Active ingredients
Minoxidil 2%
Purpose
Hair regrowth treatment
Uses
Use to regrow hair on the scalp (vertex only, see picture on side of carton)
Warnings
For external use only
Flammbel: keep away from fire or flame
Do not use if:
- your amount of hair loss is different than that shown on the side of this carton, because this product may not work for you
- you have no family history of hair loss
- your hair loss is sudden and/or patchy
- your hair loss is associated with childbirth
- you do not know the reason for your hair loss
- you are under 18 years of age. Do not use on babies and children
- your scalp is red, inflamed, irritated or painful
- you use other medicines on the scalp
Ask a doctor before use if you have
heart disease
When using this product
- do not apply on other parts of the body
- avoid contact with the eyes. In case of accidental contact, rinse eyes with large amounts of cool tap water
- some people have experienced changes in hair color and/or texture
- it takes time to regrow hair. Results may occur at 2 months with twice a day usage. For some women, you may need to use this product for at least 4 months before you see results.
- the amount of hair regrowth is different for each person. This product will not work for all women.
Stop use and ask doctor if
- chest pain, rapid heartbeat, faintness, or dizziness occurs
- sudden, unexplained weight gain occurs
- your hands or feet swell
- scalp irritation or redness occurs
- unwanted facial hair growth occurs
- you do not see hair regrowth in 4 months
May be harmful if used when pregnant or breast-feeding.
Keep out of the reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- apply one mL with dropper 2 times a day directly onto the scalp in the hair loss area
- using more or more often will not improve results
- continued use is necessary to increase and keep your hair regrowth, or hair loss will begin again
Other information
- see hair loss pictures on side of this carton
- before use, read all information on carton and enclosed leaflet
- keep the carton. It contains important information.
- In clinical studies of mostly white women aged 18-45 years with mild to moderate degrees of hair loss, the following response to 2% minoxidil topical solution was reported: 19% of women reported moderate hair regrowth after using 2% minoxidil topical solution for 8 months (19% had moderate regrowth; 40% had minimal regrowth). This compares with 7% of women reporting moderate hair regrowth after using placebo, the liquid without minoxidil in it, for 8 months (7% had moderate regrowth; 33% had minimal regrowth).
- store at USP controlled room temperature 200 to 250C (680 to 770F)
Inactive ingredients
Alcohol, Propylene Glycol, Purified Water
Questions or Comments?
Call 1-866-344-5645or visit website at honestpharma.com
Package Labeling:
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| MINOXIDIL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 87412-981-00 | Fete Health Hair Regrowth Treatment for Women | 60 mL in 1 BOTTLE, DROPPER | SOLUTION | 60 | 1 | |
| 87412-981-00 | Fete Health Hair Regrowth Treatment for Women | 1 in 1 BOX | SOLUTION | 1 | 1 |
Products#
Every source-derived product name is available through these pages.
- Fete Health Hair Regrowth Treatment for Women
- MINOXIDIL
- ALCOHOL
- PROPYLENE GLYCOL
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 87412-981 | 87412-981-00 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALCOHOL | 3K9958V90M | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| WATER | 059QF0KO0R | IACT |
| MINOXIDIL | 5965120SH1 | ACTIB |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078176-001 | THEROXIDIL | MINOXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A078176-001 | THEROXIDIL | 2% | SOLUTION / TOPICAL | 2007-11-09 | 3a93d1ddd44b… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fete Health Hair Regrowth Treatment for Women | MINOXIDIL | Honest Pharma LLC | 93f7a89b-65f1-4a58-af75-2eeb0e47a8f8 | 2026-02-11 | Warnings | 87412-981-00 87412-981 87412098100 4a89640e-7b91-0c94-e063-6294a90a8e84 93f7a89b-65f1-4a58-af75-2eeb0e47a8f8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.